Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for pH Testing of Final Product – V 2.0

Posted on By

Elixir Department: SOP for pH Testing of Final Product – V 2.0

Standard Operating Procedure for pH Testing of Final Elixir Product

Department Elixir Department
SOP No. SOP/ELX/214/2025
Supersedes SOP/ELX/214/2022
Page No. Page 1 of 7
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To lay down a standardized method for the accurate determination of pH in the final elixir formulation to ensure product stability, patient safety, and compliance with approved specifications.

2. Scope

This SOP is applicable to the Quality Control Department for the analysis of final elixir batches prior to release using a calibrated pH meter.

3. Responsibilities

  • QC Analyst:
    • Perform pH testing as per method and record results.
  • QC Supervisor:
    • Verify results and check instrument calibration status.
  • QA Officer:
    • Ensure compliance with specifications and documentation practices.

See also  Elixir Department: SOP for Use of Material Transfer Hatches - V 2.0

4. Accountability

The QC Head is accountable for the execution and review of pH results. QA is responsible for approval and regulatory compliance.

5. Procedure

5.1 Preparation

  1. Ensure the pH meter is calibrated on the day of analysis using pH 4.0, 7.0, and 9.2 buffer solutions.
  2. Record calibration details
in the Instrument Calibration Logbook.
  • Clean and dry the sample beakers and electrodes before use.
  • 5.2 Sampling

    1. Withdraw approximately 20–30 mL of well-mixed final product sample using a clean pipette or beaker.
    2. Allow the sample to equilibrate to room temperature (25 ± 2°C) before testing.

    5.3 pH Testing Procedure

    1. Rinse the electrode with distilled water and blot dry with lint-free tissue.
    2. Immerse the electrode into the sample ensuring complete submersion of the bulb.
    3. Stir gently and wait for the reading to stabilize (approx. 30–60 seconds).
    4. Record the pH value displayed by the meter.
    5. Remove the electrode, rinse, and store as per manufacturer’s instructions.

    5.4 Acceptance Criteria

    1. The pH should be within the range specified in the product specification sheet (typically 5.0–7.5 for oral elixirs unless otherwise defined).
    2. Deviation must be reported and investigated as per the deviation management SOP.

    5.5 Documentation

    1. Record the result in the pH Test Logbook (Annexure-1).
    2. Attach a copy to the corresponding Batch Manufacturing Record (BMR).
    3. Ensure details include:
      • Batch Number
      • Date and Time of Testing
      • Instrument ID
      • Sample Temperature
      • Tested By / Verified By

    6. Abbreviations

    • pH: Potential of Hydrogen
    • SOP: Standard Operating Procedure
    • QC: Quality Control
    • QA: Quality Assurance
    • BMR: Batch Manufacturing Record

    7. Documents

    1. pH Test Logbook (Annexure-1)
    2. Instrument Calibration Logbook
    3. Batch Manufacturing Record (BMR)

    8. References

    • USP General Chapter <791> – pH
    • 21 CFR Part 211.160 – Laboratory Controls
    • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: pH Test Logbook

    Date Batch No. Sample Temp (°C) Instrument ID Observed pH Specification Tested By Verified By
    11/04/2025 ELX-0425-032 25.2 PHM-03 6.7 6.0 – 7.5 Rajesh Kumar Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Updated with equilibration and verification steps GMP Compliance QA Head
    See also  Elixir Department: SOP for Issuance of Raw Materials for Elixir Production - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Handling Obsolete SOPs: Archival, Retrieval, and Inspection Readiness
    Next Post: Analytical Method Development: SOP for Comparative Evaluation of Transferred Methods – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version